Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics | $217.71 | $111.72 | 105.41% | 17.1M | $3.3B | $13.90$218.85 |
| CYCU | Cycurion | $6.32 | $2.14 | 51.20% | 33.6M | $12.1M | $2.15$2,045.10 |
| CMCT | Creative Media & Community Trust | $9.25 | $2.47 | 36.43% | 2M | $5.4M | $4.03$79.80 |
| IVVD | Invivyd | $2.35 | $0.58 | 32.77% | 135.9M | $412.6M | $0.35$2.76 |
| TOI | Oncology Institute | $3.97 | $0.89 | 28.90% | 8.6M | $288.0M | $0.13$4.88 |
| NOMA | Nomadar | $7.60 | $1.59 | 26.46% | 144.8K | - | $2.00$57.70 |
| CNTB | Connect Biopharma | $2.12 | $0.44 | 26.19% | 1M | $93.6M | $0.51$2.86 |
| PGEN | Precigen | $4.85 | $0.99 | 25.65% | 16.7M | $1.2B | $0.65$5.23 |
| OMER | Omeros | $7.82 | $1.54 | 24.52% | 170.4K | $427.4M | $2.95$13.60 |
| SRRK | Scholar Rock | $37.41 | $7.34 | 24.41% | 367.1K | $2.9B | $22.71$46.98 |
Related Articles
Featured Article
This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined
Lawrence Rothman|Oct 21, 2025
Can Oncology Institute's stock continue rewarding investors?
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Cory Renauer|Oct 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
Cory Renauer|Sep 7, 2025
Experts who follow these stocks think they can fly higher despite already gaining over 100% since the end of July.
Here's Why Everybody's Talking About Scholar Rock Right Now
Cory Renauer|Oct 9, 2024
Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.
Bargain Hunting: 2 Top Stocks to Buy Before 2025
Matt Frankel and Tyler Crowe|Sep 7, 2024
There are some cheap stocks in the market, and here are two in particular that could be worth a closer look.
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
Cory Renauer|Dec 23, 2023
The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
This $1.1 Trillion Industry Could Be Worth $3.8 Trillion by 2030: 3 Stocks Set to Skyrocket
Matt DiLallo, Tyler Crowe, and Jason Hall|Oct 22, 2023
These companies are in prime positions to capitalize on the massive and growing renewable energy market.
Bargain Hunting in Energy Stocks: 2 Renewable Stocks on Sale Right Now
Jason Hall and Tyler Crowe|Jul 2, 2023
These two are underappreciated gems.
These 2 Stocks Are Having Their Day in the Sun
Dan Caplinger|Mar 21, 2023
Markets opened higher on high hopes for a recovery from banking challenges.
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Alex Carchidi|Mar 17, 2023
Biotechs are capable of making huge gains in short periods, and they often do.
